- Home
- BKTI vs TCRX Comparison
BKTI vs TCRX Comparison
Compare BKTI & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKTI
- TCRX
- Stock Information
- Founded
- BKTI 1997
- TCRX 2018
- Country
- BKTI United States
- TCRX United States
- Employees
- BKTI N/A
- TCRX N/A
- Industry
- BKTI Radio And Television Broadcasting And Communications Equipment
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- BKTI Technology
- TCRX Health Care
- Exchange
- BKTI Nasdaq
- TCRX Nasdaq
- Market Cap
- BKTI 99.9M
- TCRX 98.5M
- IPO Year
- BKTI N/A
- TCRX 2021
- Fundamental
- Price
- BKTI $39.63
- TCRX $1.29
- Analyst Decision
- BKTI Strong Buy
- TCRX Strong Buy
- Analyst Count
- BKTI 1
- TCRX 6
- Target Price
- BKTI $40.00
- TCRX $9.83
- AVG Volume (30 Days)
- BKTI 31.9K
- TCRX 442.7K
- Earning Date
- BKTI 03-27-2025
- TCRX 03-05-2025
- Dividend Yield
- BKTI N/A
- TCRX N/A
- EPS Growth
- BKTI N/A
- TCRX N/A
- EPS
- BKTI 2.25
- TCRX N/A
- Revenue
- BKTI $76,592,000.00
- TCRX $2,816,000.00
- Revenue This Year
- BKTI $3.94
- TCRX $32.21
- Revenue Next Year
- BKTI $4.90
- TCRX $118.35
- P/E Ratio
- BKTI $17.62
- TCRX N/A
- Revenue Growth
- BKTI 3.37
- TCRX N/A
- 52 Week Low
- BKTI $11.67
- TCRX $1.28
- 52 Week High
- BKTI $43.34
- TCRX $9.69
- Technical
- Relative Strength Index (RSI)
- BKTI 67.35
- TCRX 31.10
- Support Level
- BKTI $28.35
- TCRX $1.28
- Resistance Level
- BKTI $43.34
- TCRX $1.76
- Average True Range (ATR)
- BKTI 2.75
- TCRX 0.17
- MACD
- BKTI 1.10
- TCRX -0.01
- Stochastic Oscillator
- BKTI 71.00
- TCRX 16.39
About BKTI BK Technologies Corporation
BK Technologies Corp a holding company, operates primarily through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.